Viewing nowYoungil Sitagliptin Tablets 100 mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

MFDS item code 202005307 · Approved 2020.07.23 · Insurance code 649405540
Improvement of blood sugar control in type 2 diabetes
This medication assists in improving blood sugar control for patients with type 2 diabetes in conjunction with diet and exercise. It can also be used as monotherapy, and if blood sugar control is difficult with monotherapy due to a lack of prior diabetes medication experience, it is taken in conjunction with metformin. Additionally, this medication is used when blood sugar control is insufficient with sulfonylureas, metformin, thiazolidinediones, or insulin in monotherapy. If blood sugar control is not attained with combinations of sulfonylureas and metformin, thiazolidinediones and metformin, or insulin and metformin, this medication can be added to enhance therapeutic efficacy. This combination therapy effectively improves blood sugar control.
The recommended dosage for this medication is 100 mg once daily as monotherapy or in combination therapy, with a maximum daily dosage of 100 mg. This medication can be taken regardless of meals. In patients with renal impairment, dosage adjustments are necessary based on kidney function. Mildly impaired renal function patients (eGFR 60-90 mL/min/1.73 m2) and moderately impaired renal function patients (eGFR 45-60 mL/min/1.73 m2) require dosage adjustments.
This medication may cause rare but severe allergic reactions, and if symptoms such as rash, difficulty breathing, or swelling of the face or neck occur after taking the medication, it should be discontinued immediately and a doctor consulted. During the use of this medication, acute pancreatitis may develop, so if severe abdominal pain or vomiting occurs, immediate medical attention is required. This medication should not be used by patients with type 1 diabetes or diabetic ketoacidosis, nor should it be administered to those with known allergies to this medication or its components. Patients with impaired kidney function should have their dosage adjusted, and regular kidney function tests are necessary before and during treatment. Since there is a risk of hypoglycemia, caution should be exercised for signs of low blood sugar while using this medication in conjunction with insulin or sulfonylureas, and dosage adjustments for those medications may be necessary. If severe joint pain occurs during the use of this medication, a doctor should be informed, and immediate medical attention is required for blisters or skin lesions. Pregnant or nursing women should not use this medication, and its safety and efficacy have not been established for children or adolescents under 18 years of age. Elderly patients may be at risk for diminished kidney function, so dosage adjustments and regular kidney function checks are necessary. In case of overdose, measures should be taken to remove the drug from the gastrointestinal tract, monitor the condition through ECG, and if necessary, some drug removal may be achieved through hemodialysis. Interactions with other medications taken concurrently with this medication are generally minimal, but if taking digoxin or cyclosporine, healthcare professionals should be informed for appropriate management. While using this medication, side effects such as infections, headaches, indigestion, and diarrhea may occur; if symptoms are severe or prolonged, consultation with a doctor is recommended.
Urticaria, severe swelling (edema), anaphylaxis, angioedema, rash, exfoliative skin disease, Stevens-Johnson syndrome, acute pancreatitis (fatal/non-fatal hemorrhagic or necrotizing pancreatitis), acute renal failure, bullous pemphigoid, severe and disabling arthralgia, cardiac arrest, elevated liver enzymes, liver abnormalities (jaundice), pneumonia, diabetes complications, metabolic acidosis, severe hypoglycemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will ensure the medication's efficacy is maintained safely.
Light orange, round, double convex, film-coated tablet
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.